Mitera Biosciences
PrivateLast Round
Seed Round
Apr 21, 2026
Total Funding Raised
$1.75M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Mitera Biosciences operates in Healthcare & Life Sciences and is based in Bellevue, Washington. Its latest recorded funding round was a Seed round in December 2025.
Mitera Biosciences is a biotechnology company that develops investigational therapeutics for the treatment of autoimmune and alloimmune disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mitera Biosciences Comparables
Compare Mitera Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GentiBio | 81% | |
| RegCell, Inc. | 79% | |
| Egle Therapeutics | 78% |
For institutional investors. Book with your work email.
Mitera Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 21, 2026 | ||||
| Seed | Dec 30, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Mitera Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cedars Sinai Health Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 25, 2026
Monthly visitors increased 177% MoM, reaching 1K.
- May 15, 2026
Monthly visitors grew 631% MoM, from 51 to 373.
For institutional investors. Book with your work email.
Mitera Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mitera Biosciences's valuation, stock price, and market status.
Is Mitera Biosciences a public or private company?
Mitera Biosciences is a private company.
What is the current stock price of Mitera Biosciences?
Mitera Biosciences is a private company, so its shares have no public market price. Caplight tracks Mitera Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mitera Biosciences worth (valuation)?
Valuation information for Mitera Biosciences is not publicly available.
Can I buy Mitera Biosciences stock?
Mitera Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mitera Biosciences's last funding round?
Mitera Biosciences's most recent funding round was Seed Round on April 21, 2026.
Who are the main investors in Mitera Biosciences?
Key investors in Mitera Biosciences include Cedars Sinai Health Ventures.
Will Mitera Biosciences IPO soon?
No public IPO plans have been announced for Mitera Biosciences.
How can I track Mitera Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Mitera Biosciences's shares on secondary markets.